NAMS
NewAmsterdam Pharma Company N.V. · Healthcare
Chief Accounting Officer Louise Frederika Kooij sold $707K of NewAmsterdam Pharma Company N.V.
Sold$707,400
$15.72Price
45,000Shares
−100%Stake
What NAMS did after the filing
- The stock from Tue, Oct 1 close, $17.29
- +43.2%
- S&P 500, same days
- +5.0%
Measured over 30 trading days, to the Nov 12 close.
Traded Tue, Oct 1. Filed Tue, Oct 1, 1:23 PM ET, during the session. Returns use the Oct 1 close and the Nov 12 close. Not investment advice.